From once-weekly subcutaneously injectable medicines agonizing the glucagon-like peptide 1 receptor (GLP-1R), longer-acting candidates allowing once-monthly administration may become the next ...
Led by technology companies, the total market capitalisation of top 50 firms in the Asia-Pacific (APAC) region surged to $8.1 ...